invision sally jobe logo

Invision Sally Jobe & Clairity AI

Beyond Screening Towards Certainty
For over 45 years, Invision Sally Jobe has been a leader in breast imaging in Colorado, committedto helping you better understand your breast health through the latest innovations in care.That is why we partnered with Clairity AI, to offer a first-of-its-kind, FDA-authorized tool toestimate your 5-year risk of developing breast cancer. We are proud to be the only imaging centerin the region offering this innovative technology to our patients. 

Clairity AI is designed to generate a 5-year breast cancer risk prediction using only the standardmammographic images obtained during your annual screening mammogram. It can identify high-risk patients who may be missed by traditional risk assessment tools; particularly women under 50 without a family history, by analyzing subtle image patterns not visible to the human eye.
The result is an unbiased risk score that does notrely on age, ethnicity, or personal or family history.
Clairity AI has demonstrated equitable performance across race, age, and breast density levels.

New AI Model Uses Mammograms to Predict Breast Cancer Risk


UNDERSTANDING YOUR RESULTS
Your Clairity AI 5-year breast cancer risk score will be included in your screening mammogram report. If your score is elevated (1.7% or higher), the radiologist mayrecommend supplemental breast MRI screening. If your score is within the average range, you should continue with your annual screening schedule. Because breastcancer risk can change over time, it is recommended that the Clairity AI assessment be repeated at your next screening mammogram.

High-Risk: Above 3.0%

Elevated Risk: 1.7–3.0%

Average Risk: Below 1.7%

Note: A higher number does not mean cancer is present. It only means your futurerisk may be higher than other women.

Beyond screening. Toward certainty.


Beyond Screening Towards Certainty